Poland· PL-100482169
Bimervax
A covid-19, protein-untereinheit product containing szczepionka przeciw covid-19 (rekombinowana, z adiuwantem), registered in Poland by Hipra Human Health, S.L.U.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Covid-19, protein-untereinheit is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BN04 (covid-19, protein-untereinheit), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Covid-19, protein-untereinheit · ATC J07BN04
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Szczepionka przeciw COVID-19 (rekombinowana, z adiuwantem)
- Manufacturer
- Hipra Human Health, S.L.U.
- Country
- Poland (PL)
- ATC code
- J07BN04
- ATC class
- Covid-19, Protein-Untereinheit
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BN04
Covid-19, protein-untereinheit, as other registers publish it.
- BelgiumBimervaxHipra Human Health
- FinlandBIMERVAXHipra Human Health S.L.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- IcelandBIMERVAXHipra Human Health S.L.
- DenmarkBIMERVAXHipra Human Health S.L.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/56e99617-ba7a-4305-aedf-7c0f0b5a6a46 GET /v1/drugs/56e99617-ba7a-4305-aedf-7c0f0b5a6a46?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsja do wstrzykiwań",
"source": "urpl",
"strength": "-",
"packaging": "Rp ¦ EU/1/22/1709/001 ¦ 149866\n10 fiol. 5 ml 10 dawek/fiol.\nRp ¦ EU/1/22/1709/002 ¦ 154532\n5 fiol. 0,5 ml (1 dawka/fiol.)\nRp ¦ EU/1/22/1709/004 ¦ 154533\n20 fiol. 0,5 ml (1 dawka/fiol.)\nRp ¦ EU/1/22/1709/003 ¦ 154534\n10 fiol. 0,5 ml (1 dawka/fiol.)",
"substance": "Heterodimer fuzyjny domeny wiążącej receptor (RBD) rekombinowanego białka kolca (S) wirusa SARS-CoV-2 (szczepy B.1.351 i B.1.1.7) z adiuwantem SQBA 40 mcg/0.5 ml",
"common_name": "Szczepionka przeciw COVID-19 (rekombinowana, z adiuwantem)",
"pl_product_id": "100482169",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about covid-19, protein-untereinheit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.